What does Praxis Precision Medicines, Inc. do?

Jun 22 2025 06:55 PM IST
share
Share Via
Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system disorders. It has a market cap of $885.24 million and reported a net profit loss of $69 million as of March 2025.
Overview:
Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company engaged in developing therapies for central nervous system disorders characterized by neuronal imbalance, operating within the Pharmaceuticals & Biotechnology industry and classified as a micro-cap company.

Financial Snapshot:
- Most recent Net Profit: -69 Million (Quarterly Results - Mar 2025)
- Market-cap: USD 885.24 Million (Micro Cap)

Key Metrics:
- P/E: NA (Loss Making)
- Industry P/E: NA
- Dividend Yield: 0.00%
- Debt Equity: -0.74
- Return on Equity: -48.40%
- Price to Book: 2.02

Contact Details:
- Address: 101 Main Street, #1210, Suite 1210, CAMBRIDGE MA: 02142
- Tel: 1 617 9492220
- Website: https://praxismedicines.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News